COVID-19 Impact on Medtronic Plcs Revenue and Operations (Medical Devices)

COVID-19 Impact on Medtronic Plcs Revenue and Operations (Medical Devices)



Medtronic Plc (Medtronic), formerly Medtronic Inc, is a medical technology company which designs, develops, manufactures and markets a wide range of medical devices, headquartered in Ireland with global manufacturing and sales reach. Medtronics product range include the solutions for the treatment of heart failure; heart valve disorders; diseases of the coronary artery; aortic; peripheral vascular; venous renaland neurological diseases; spine and musculoskeletal disorders; and diseases of the ear, nose and throat. It also provides biologic solutions for the orthopedic and dental markets. The report, COVID-19 Impact on Medtronic Plcs Revenue and Operations (Medical Devices) presents a deep dive analysis into how Medtronic Plc is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how Medtronic Plc is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Key Highlights

- The spread of the disease in recent days has put a much large proportion of Medtronic’s revenue at risk.
- In particular the heavy impact in Europe and rapid rise of COVID-19 cases in the US mean that the general outlook for sales has slightly impacted in the past quarter.

Scope

The report provides a comprehensive analysis of the impact of COVID-19 on Medtronic Plc -
- It provides insights on Medtronic Plcs exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.

Reasons to Buy

- An overview of how Medtronic Plc will be affected by the COVID-19 pandemic.


COVID-19 impact analysis on Medtronic - Key Findings
Medtronic Key Facts
Geographic spread analysis - COVID-19 vs Medtronic sales
The impact of COVID-19 on regional GDP per capita levels
Medtronics exposure: revenues by region and market vs regional impact levels
Medtronic : revenue impact by region and market for 2020
Operational reactions from Medtronic: indications from recruitment trends
Operational reactions from Medtronic:indications from US pricing trends
Contact us


Global Peptide Therapeutics Market (2021 Edition) – Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced), Application,, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

Executive The Global Peptide Therapeutics Market is valued at USD 32.1 Billion in the year 2020. The growth of Peptide Therapeutics is directly associated with drug development. New drug discovery

USD 2400 View Report

COVID-19 Impact on Anheuser-Busch InBev, Update 2021

COVID-19 Impact on Anheuser-Busch InBev, Update 2021 COVID-19 Impact on Anheuser-Busch InBev, Update 2021 reports key findings as of 23rd March, 2021 based on market analysis and brand diversification by industry

USD 1450 View Report

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 Update

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 UpdateThis 62-page PowerPoint based report gives an important update to the previous year with an expert analysis on how COVID-19 is

USD 1495 View Report

Global Peptide Therapeutics Market (2021 Edition) – Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced), Application,, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

Executive The Global Peptide Therapeutics Market is valued at USD 32.1 Billion in the year 2020. The growth of Peptide Therapeutics is directly associated with drug development. New drug discovery

USD 2400 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available